DE69906091D1 - Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis - Google Patents

Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis

Info

Publication number
DE69906091D1
DE69906091D1 DE69906091T DE69906091T DE69906091D1 DE 69906091 D1 DE69906091 D1 DE 69906091D1 DE 69906091 T DE69906091 T DE 69906091T DE 69906091 T DE69906091 T DE 69906091T DE 69906091 D1 DE69906091 D1 DE 69906091D1
Authority
DE
Germany
Prior art keywords
treating herpes
producing
lithium gluconate
medicinal product
seborrhoic dermatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69906091T
Other languages
English (en)
Other versions
DE69906091T2 (de
Inventor
Jacques Bodin
Brigitte Dreno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABCATAL MONTROUGE
Original Assignee
LABCATAL MONTROUGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABCATAL MONTROUGE filed Critical LABCATAL MONTROUGE
Application granted granted Critical
Publication of DE69906091D1 publication Critical patent/DE69906091D1/de
Publication of DE69906091T2 publication Critical patent/DE69906091T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69906091T 1998-09-03 1999-09-03 Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis Expired - Lifetime DE69906091T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9811025A FR2783424B1 (fr) 1998-09-03 1998-09-03 Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique
PCT/FR1999/002108 WO2000013649A2 (fr) 1998-09-03 1999-09-03 Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique

Publications (2)

Publication Number Publication Date
DE69906091D1 true DE69906091D1 (de) 2003-04-24
DE69906091T2 DE69906091T2 (de) 2003-11-20

Family

ID=9530089

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906091T Expired - Lifetime DE69906091T2 (de) 1998-09-03 1999-09-03 Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis

Country Status (9)

Country Link
EP (1) EP1107766B1 (de)
AT (1) ATE234620T1 (de)
AU (1) AU5521099A (de)
CA (1) CA2341566C (de)
DE (1) DE69906091T2 (de)
ES (1) ES2193741T3 (de)
FR (1) FR2783424B1 (de)
PT (1) PT1107766E (de)
WO (1) WO2000013649A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416981B1 (en) 2000-05-23 2002-07-09 Nec Partnership Production of gluconate salts
EP1948236B1 (de) * 2005-09-27 2021-03-03 Special Water Patents B.V. Methoden und zusammensetzungen zur behandlung der haut

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8318912D0 (en) * 1983-07-13 1983-08-17 Horrobin D F Compositions for treatment of skin/hair
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
AU681629B2 (en) * 1993-03-12 1997-09-04 Keele University Therapeutic compositions containing a lithium compound and silica

Also Published As

Publication number Publication date
WO2000013649A2 (fr) 2000-03-16
FR2783424A1 (fr) 2000-03-24
EP1107766B1 (de) 2003-03-19
AU5521099A (en) 2000-03-27
DE69906091T2 (de) 2003-11-20
CA2341566A1 (fr) 2000-03-16
FR2783424B1 (fr) 2002-10-04
EP1107766A2 (de) 2001-06-20
WO2000013649A3 (fr) 2000-07-20
ES2193741T3 (es) 2003-11-01
CA2341566C (fr) 2009-11-24
ATE234620T1 (de) 2003-04-15
PT1107766E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
DE69428268T2 (de) Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma
ATE324884T1 (de) Verwendung von gamma-linolensäure oder dihomogammalinolensäure zur herstellung eines medikaments zur behandlung von huntington's chorea
ATE231885T1 (de) Verwendung von komplement-inhibitoren zur herstellung eines arzneimittels zur prophylaxe und therapie von entzündlichen darm- und hauterkrankungen sowie purpura
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE3876877T2 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATE203403T1 (de) Verwendung von prolin als einziger therapeutischer wirkstoff zur herstellung eines arzneimittels zur behandlung von rheumatischen erkrankungen und von chronischen und traumatisch bedingten schmerzzuständen
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
DE3688038T2 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE206914T1 (de) Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
ATE314068T1 (de) Behandlung von seborrhoischer dermatitis
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
ATE274349T1 (de) Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
HUP9902029A2 (hu) Sebgyógyulási folyamat szabályozása
DE69906091T2 (de) Verwendung von lithium-gluconat zur herstellung eines arzneimittels zur behandlung von herpes und seborrhoischer dermatitis
FR2712809B1 (fr) Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
CN1048893C (zh) 一种治疗骨质增生药油及制作方法
DE69433923D1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition